Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Dodge & Cox Stock I

Vanguard Total Stock Mkt Idx Inv

T. Rowe Price US Lg-Cp Equity Inc Comp

T. Rowe Price Equity Income

American Century U.S. Mid Cap Value

American Century Mid Cap Value Inv

iShares Core S&P 500 ETF

Victory Sycamore Established Value R

Vanguard PRIMECAP Inv

Allspring Special US Mid Cap Value Eq

Allspring Special Mid Cap Value Inst

Vanguard Value Index Inv

Vanguard Institutional 500 Index Trust

Vanguard Mid Cap Index Institutional

VanEck Morningstar Wide Moat

VanEck Morningstar Wide Moat ETF

T. Rowe Price Mid-Cap Value

T. Rowe Price US Mid-Cap Value Equity

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

Vanguard Group Inc

Dodge & Cox

Victory Capital Management Inc.

JPMorgan Chase & Co

Boston Partners Global Investors, Inc

Allspring Global Investments Holdings, LLC

Camber Capital Management LLC

NORGES BANK

Northern Trust Corp

Morgan Stanley - Brokerage Accounts

Bank of America Corp

Legal & General Group PLC

BlackRock Inc

T. Rowe Price Associates, Inc.

State Street Corp

American Century Companies Inc

PRIMECAP Management Company

Geode Capital Management, LLC

Amvescap Plc.

Van Eck Associates Corporation

Zimmer Biomet Holdings Inc

Mr. Ivan  Tornos

COO, President, CEO & Director

Mr. Suketu P. Upadhyay

CFO and Executive VP of Finance, Operations & Supply Chain

Mr. Chad F. Phipps J.D.

Senior VP, General Counsel & Secretary

Mr. Sang  Yi

President of Asia Pacific

Mr. Wilfred  van Zuilen

Group President of Europe, Middle East & Africa

Mr. Paul A. Stellato

VP, Controller & Chief Accounting Officer

Mr. Shaun  Braun

Senior VP & Chief Information and Technology Officer

Ms. Rachel H. Ellingson

Senior VP & Chief Administrative Officer

Mr. David M. DeMartino

Senior VP of Investor Relations

Ms. Angela  Main

Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific

ZBH's next earnings is on February 6, 2025 (Before Market Open)

ZBH's latest dividend is 0.24 USD on June 26, 2024

Zimmer Biomet Holdings Inc (ZBH) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Zimmer Biomet Holdings Inc (ZBH) Earnings Report Date and History | NYSE

ZBH's next earnings is on February 6, 2025 (Before Market Open)

When is the earnings report for ZBH?

ZBH Earnings History

ZBH's latest dividend is 0.24 USD on June 26, 2024

ZBH Stock Discussion Forum and Message Board

News for NYSE: ZBH